Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

E-Scape Bio obtains rights to S1P5 receptor agonists from AbbVie for lysosomal storage disorders

June 13, 2018

BridgeBio to acquire ALXN-1101 from Alexion for MoCD type A

June 13, 2018

Merck & Co. patents DGAT2 inhibitors

June 12, 2018

Saniona to study Tesomet in phase IIa trial for hypothalamic obesity

June 11, 2018

Prolia approved in Europe for patients with glucocorticoid-induced osteoporosis

June 11, 2018

FDA approves IND application for clinical study of RK-01

June 11, 2018

Updated interim data from phase I/II study of lumasiran for primary hyperoxaluria type 1

June 8, 2018

Seoul National University creates adenoviral vector encoding CRY1

June 8, 2018

FDA grants orphan drug designation to TransCon PTH

June 7, 2018

S1P regulation key for bone quality and may constitute a therapeutic target in osteoporosis

June 7, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...